Story
Meta Connect 2026 Preview: Muse AI, New Smart Glasses in Focus as Wells Fargo Lifts Price Target to $796

Summary
Meta Platforms is set to showcase its latest advancements in AI and hardware at its Connect 2026 conference this week, with analysts focused on the 'Muse' AI agent and new smart glasses. Ahead of the event, Wells Fargo raised its price target on the stock to $796, citing the company's progress in artificial intelligence.
Meta Platforms (NASDAQ: META) is poised to unveil its latest hardware and artificial intelligence strategy at its annual Connect conference, scheduled for September 23-24. The event is expected to feature significant updates on smart glasses, a new mixed-reality device, and the company's new AI agent, Muse, which is anticipated to be a central focus.
Ahead of the conference, Wall Street sentiment is turning more positive, with Wells Fargo raising its price target on Meta stock. The bank reiterated its "Overweight" rating and increased its target to $796 from a previous $640, implying approximately 19% potential upside from the most recent closing price mentioned in the source report. Wells Fargo noted that Meta's recent AI model releases and the early performance of Muse give the company a compelling "story to tell."
AI and Hardware in the Spotlight
This year's event is expected to shift focus from a purely virtual reality-centric theme to a broader integration of AI, augmented reality (AR), and wearable technology. Key announcements are anticipated across several product lines:
- Muse AI Agent: Unlike traditional chatbots, Muse is designed as a personal AI agent that can perform tasks on behalf of the user, such as sending emails or booking travel. Meta is expected to detail how Muse will integrate with its wearable devices, particularly smart glasses.
- Smart Glasses: A new generation of smart glasses is anticipated, with reports suggesting the development of a version without a camera. This design could alleviate privacy concerns and allow for a smaller form factor, relying on an increased number of microphones for voice interaction with the Muse AI.
- 'Phoenix' MR Device: A new, lightweight mixed-reality device codenamed "Phoenix" may also be unveiled. Leaked images suggest a design resembling large goggles, which could be significantly lighter than traditional VR headsets by offloading computing and battery components to a separate, wired module. The device is rumored to be one of the first to use Qualcomm's new Snapdragon Reality Elite chip.
AdMarket Implications and Strategic Vision
The announcements at Connect are crucial for Meta's long-term strategy of building a post-smartphone computing platform. By integrating its AI agent directly into wearables, the company aims to create a new ecosystem for developers and users. The success of this strategy hinges on attracting third-party application developers to build for its smart glasses, an area where expansion has been gradual.
Analysts are closely watching the potential monetization of these new technologies. Oppenheimer analyst Jason Helfstein, cited in media reports, calculated that for Meta to generate approximately $28 billion in annual revenue from a potential $20-per-month Muse subscription, it would need around 115 million paying users. While Helfstein expressed caution about reaching such a scale, the calculation highlights the significant revenue potential Wall Street is beginning to model for Meta's AI initiatives.
Read next
More on Stocks
Danaher's Valuation Discount to Thermo Fisher Sparks Pairs Trade Analysis
A notable valuation gap between life sciences giants Danaher (DHR) and Thermo Fisher Scientific (TMO) is drawing analyst attention. The analysis suggests Danaher's lower multiples could present a market-neutral pairs trade opportunity against the more richly valued Thermo Fisher.

IBM Trades at Discount But Faces Investor Scrutiny Ahead of Q3 Earnings
International Business Machines (IBM) is trading below its estimated fair value, but sluggish growth in its consulting division and bearish technical signals are creating headwinds as the company approaches its October earnings report.

AI Leaders Anthropic and OpenAI Take Divergent IPO Paths Amid Regulatory Debate
Leading AI firms Anthropic and OpenAI are navigating the complex landscape of potential government regulation as they plan their public market debuts, with each adopting a distinct strategy to manage investor perceptions and market timing.

Grail Shares Surge 35% as FDA Staff Finds No Major Issues With Galleri Cancer Test
Shares of Grail soared after U.S. Food and Drug Administration staff reviewers found no major safety or accuracy concerns with its Galleri multi-cancer blood test ahead of a key advisory panel meeting.